Use of Activated Recombinant Human Factor VII in Cardiac Surgery

Stopped early · Phase 2

Conditions studied: Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass

In brief

This trial is conducted in Africa, Asia, Europe, South America and the United States of America (USA). The trial is planned to investigate the safety and efficacy of NovoSeven® in the management of post-operative bleeding in patients following cardiac surgery.

Key facts

Study ID

NCT00154427

Run by

Novo Nordisk A/S

People needed

172

Starts

2004-08-01

Expected to finish

2007-11-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Post-operative bleeding according to pre-defined criteria for critical bleeding

Where it is running

• Novo Nordisk Investigational Site — Tucson, Arizona, United States
• Novo Nordisk Investigational Site — San Francisco, California, United States
• Novo Nordisk Investigational Site — Denver, Colorado, United States
• Novo Nordisk Investigational Site — Atlanta, Georgia, United States
• Novo Nordisk Investigational Site — Baltimore, Maryland, United States
• Novo Nordisk Investigational Site — Boston, Massachusetts, United States
• Novo Nordisk Investigational Site — Camden, New Jersey, United States
• Novo Nordisk Investigational Site — Syracuse, New York, United States
• Novo Nordisk Investigational Site — The Bronx, New York, United States
• Novo Nordisk Investigational Site — The Bronx, New York, United States
• Novo Nordisk Investigational Site — Cleveland, Ohio, United States
• Novo Nordisk Investigational Site — Oklahoma City, Oklahoma, United States
• Novo Nordisk Investigational Site — Portland, Oregon, United States
• Novo Nordisk Investigational Site — Danville, Pennsylvania, United States
• Novo Nordisk Investigational Site — Houston, Texas, United States
• Novo Nordisk Investigational Site — Norfolk, Virginia, United States
• Novo Nordisk Investigational Site — Richmond, Virginia, United States
• Novo Nordisk Investigational Site — Buenos Aires, Argentina
• Novo Nordisk Investigational Site — Caba, Argentina
• Novo Nordisk Investigational Site — Capital Federal, Argentina
• Novo Nordisk Investigational Site — Corrientes, Argentina
• Novo Nordisk Investigational Site — Rosario, Argentina
• Novo Nordisk Investigational Site — São Paulo, Brazil
• Novo Nordisk Investigational Site — København Ø, Denmark
• Novo Nordisk Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.